Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin RinGlar vs Lantus in Type 1 Diabetes
NCT04022993Phase 3Completed
- Sponsor
- Geropharm
- Start
- Jul 2018
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Geropharm. Started Jul 2018; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04022993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022993.